Fatazadeh M, Schwartz RA. - Human herpes simplex virus infections : epidemiology, pathogenesis, symptomatology, diagnosis and management. J Am Acad Dermatol, 2007, 57, 737-763.
Nikkels AF, Piérard GE. - Treatment of muco-cutaneous presentations of herpes simplex virus infections. Am J Clin Dermatol, 2002, 3, 475-48.
Petit L, Braham C, Nikkels AF, et al. - Pharma clinics. Comment je traite... Un herpès labial récurrent. Rev Med Liège, 2002, 57, 67-71.
Nikkels AF. - Contribution à l'étude des infections mucocutanées inhabituelles et systémiques par á. herpesviridae. Thèse d'Agrégation de l'Enseignement Supérieur, 2006, Université de Liège.
Nikkels AF, Hermanns-Lê T, Nikkels-Tassoudji N, et al. - Diagnostic des infections cutanées par les virus de types herpes simplex et varicelle zona. Rev Med Liège, 1993, 48, 401-405.
Spruance SL, Aoki FY, Tyring S, et al. - Short-course therapy for recurrent genital herpes and herpes labialis. J Fam Pract, 2007, 56, 30-36.
Amir J, Harel L, Smetana Z, et al. - Treatment of herpes simplex gingovostomatitis with aciclovir in children : a randomised double-blind placebo controlled study. Br Med J, 1997, 314, 1800-1803.
Hamuy R, Berman B. - Treatment of herpes simplex virus infections with topical antiviral agents. Eur J Dermatol, 1998, 8, 310-319.
Spruance SL, Stewart JC, Freeman DJ, et al. - Early application of topical 15% idoxuridine in dimethyl sulfoxide shortens the course of herpes simplex labialis: a multicenter placebo-controlled trial. J Infect Dis, 1990, 161, 191-197.
Bernard PH, Mounier M, Dupuy P. - Randomized, open-labelled comparison between an idoxuridine 10% gel and acyclovir 5% cream in recurrent herpes labialis. J Eur Acad Dermatol Venereol, 2003, 17, 246.
Spruance SL, Nett R, Marbury T, et al. - Acyclovir cream for treatment of herpes simplex labialis : results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrob Agents Chemother, 2002, 46, 2238-2243.
Trottet L, Owen H, Holme P, et al. - Are all aciclovir cream formulations bioequivalent ? Int J Pharm, 2005, 304, 63-71.
Spruance SL, Rea TL, Thoming C, et al. - Penciclovir cream for the treatment of herpes simplex labialis. A randomized multicenter, double-blind, placebo-controlled trial. JAMA, 1997, 277, 1374-1379.
Raborn GW, Martel AY, Lassonde M, et al. - Effective treatment of herpes simplex labialis with penciclovir cream : combined results of two trials. J Am Dent Assoc, 2002, 133, 303-309.
Lin L, Chen XS, Cui PG, et al. - Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis : a randomized, double-blind, multicentre, aiclovir-controlled trial. J Dermatol Treat, 2002, 13, 222-230.
Kaminester LH, Pariser RJ, Pariser DM, et al. - A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis. J Am Acad Dermatol, 1999, 41, 996-1001.
Bodsworth NJ, Bayerl C, Cunningham A, Silny W. - No significant analgesic benefit of adding lidocaine 2% to aciclovir 5% cream as treatment of episodes of herpes labialis. Herpes, 2003, 10, 53-54.
Woodridge P. - The use of betadine antiseptic paint in the treatment of Herpes simplex and Herpes Zoster. J Int Med Res, 1977, 5, 378-381.
Simmons A. - An open-label study conducted to evaluate the efficacy of Betadine cold sore paint. Dermatology, 1997, 195, Suppl 2:85-8.
Karlsmark T, Goodman JJ, Drouault Y, et al. - Randomized clinical study comparing Compeed° cold sore patch to acyclovicr cream 5% in the treatment of herpes simplex labialis. JEADV, in press.
Elish D, Singh F, Weinberg JM. - Therapeutic options for herpes labialis, I : Oral agents. Cutis, 2004, 74, 31-34.
Ferniano F, Gombos F, Scully C. - Recurrent herpes labialis : efficacy of topical therapy compared with aciclovir. Oral Dis, 2001, 7, 31-32.
Piérard GE, Nikkels AF. - Le valaciclovir (Zelitrex®). Rev Med Liège, 1997, 52, 553-555.
Wu JJ, Brentjens MH, Torres G, et al. - Valacyclovir in the treatment of herpes simplex, herpes zoster and other viral infections. J Cutan Med Surg, 2003, 7, 372-378.
Spruance SL, Rowe NH, Raborn GW, et al. - Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis : A double-blind, dose-ranging, placebo-controlled, multicenter trial. J Infect Dis, 1999, 179, 303-310.
Spruance SL, Jones TM, Blatter MM, et al. - High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores : results of two randomized, placebo-controlled, multicenter studies. Antimicrob Agents Chemother, 2003, 47, 1072-1080.
Spruance SL, Bodsworth N, Resnick H, et al. - Single-dose, patient-initiated famciclovir : a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis. J Am Acad Dermatol, 2006, 55, 47-53.
Chosidow O, Drouault Y, Garraffo R, et al. - Valaciclovir as a single dose during prodrome herpes facialis : a pilot randomized double blind clinical trial. Br J Dermatol, 2003, 148, 142-146.
Evans TG, Bernstein DI, Raborn GW, et al. - Double-blind, randomized, placebo-controlled study of topical 5% aciclovir-1% hydrocortisone cream ((ME-609) for treatment of UV radiation-induced herpes labialis. Antimicrob Agents Chemother, 2002, 46, 1870-1874.
Spruance SL, McKeough MB. - Combination treatment with famciclovir and a topical coritocosteroid gel versus famciclovir alone for experimental ultraviolet radiation-induced herpes simplex labialis : a pilot study. J Infect Dis, 2000, 181, 1906-1910.
Hull C, McKeough M, Sebastian K, et al. - Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis : a patient-initiated, double-blind, placebo-controlled trial. J Am Acad Dermatol, 2008, 58, AB92 P1800.
Rooney JF, Bryson Y, Mannix ML, et al. - Prevention of ultraviolet light induced herpes labialis by sunscreen. Lancet, 1991, 338, 1419-1422.
Spruance SL, Hamill ML, Hoge WS, et al. - Acyclovir prevents reactivation of herpes simplex labialis in skiers. JAMA, 1998, 260, 1597-1599.
Spruance SL. - Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis. J Med Virol, 1993, 1, 27-32.
Baker D, Eisen D. - Valacyclovir for prevention of recurrent herpes labialis : 2 double-blind, placebo-controlled studies. Cutis, 2003, 71, 239-242.
Hippmann G, Wekkeli M, Rosenkranz AR, et al, - Nonspecific immune stimulation with BCG in Herpes simplex recidivans. Follow-up 5 to 10 years after BCG vaccination. Wien Klin Wochenschr, 1992, 104, 200-204.
Bernstein DI, Spruance SL, Arora SS, et al. - Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: a pilot study. Clin Infect Dis, 2005, 41, 808-814.
Nabors MW, Francis CK, Kobrine AI. - Reactivation of herpesvirus in neurosurgical patients. Neurosurgery 1986, 19, 599-603.
Miller CS, Cunningham LL, Lindroth JE, Avdiushko SA. - The efficacy of valaciclovir in preventing recurrent herpes simplex virus infections associated with dental procedures. J Am Dent Assoc, 2004, 135, 1311-1318.
Bissacia E, Scarborough D. - Herpes simplex virus prophylaxis with famciclovir in patients undergoing aeshetic facial CO2 laser resurfacing. Cutis, 2003, 72, 327-328.
Gilbert S, McBurney E. - Use of valacyclovir for herpes simplex virus-1 (HSV-1) prophylaxis after facial resurfacing : a randomized clinical trial of dosing regimens. Dermatol Surg, 2000, 26, 50-54.
Beeson WH, Rachel JD. - Valacyclovir prophylaxis for herpes simplex virus infection or infection recurrence following laser skin resurfacing. Dermatol Surg, 2002, 28, 331-336.
